Selected research
Market Analysis & Forecast
Global Next Generation DNA Sequencing Market Analysis and Forecast 2026-2032
Market perspective
The global Next Generation DNA Sequencing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Next Generation DNA Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Next Generation DNA Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Next Generation DNA Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Next Generation DNA Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Next Generation DNA Sequencing include Quest Diagnostics Incorporated, ARUP Laboratories, Applied Biological Materials, Inc. (abm), Novogene Co, Ltd., Azenta Life Sciences (GENEWIZ), NanoString, Illumina, Inc., PacBio and Veritas, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Next Generation DNA Sequencing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Next Generation DNA Sequencing, also provides the revenue of main regions and countries. Of the upcoming market potential for Next Generation DNA Sequencing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Next Generation DNA Sequencing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Next Generation DNA Sequencing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Next Generation DNA Sequencing revenue, projected growth trends, production technology, application and end-user industry.
Next Generation DNA Sequencing Segment by Company
Quest Diagnostics Incorporated
ARUP Laboratories
Applied Biological Materials, Inc. (abm)
Novogene Co, Ltd.
Azenta Life Sciences (GENEWIZ)
NanoString
Illumina, Inc.
PacBio
Veritas
BGI (Beijing Genomics Institute)
Gene by Gene Ltd.
Lucigen Corporation
Next Generation DNA Sequencing Segment by Type
Solexa Sequencing
454 Sequencing
Proton / PGM Sequencing
Next Generation DNA Sequencing Segment by Application
Universities & Other Research Entities
Hospitals & Clinics
Pharma & Biotech Entities
Others
Next Generation DNA Sequencing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Next Generation DNA Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Next Generation DNA Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Next Generation DNA Sequencing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Next Generation DNA Sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Next Generation DNA Sequencing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Next Generation DNA Sequencing revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Solexa Sequencing
- 454 Sequencing
- Proton / PGM Sequencing
Applications
- Universities & Other Research Entities
- Hospitals & Clinics
- Pharma & Biotech Entities
- Others
Companies covered
- Quest Diagnostics Incorporated
- ARUP Laboratories
- Applied Biological Materials, Inc. (abm)
- Novogene Co, Ltd.
- Azenta Life Sciences (GENEWIZ)
- NanoString
- Illumina, Inc.
- PacBio
- Veritas
- BGI (Beijing Genomics Institute)
- Gene by Gene Ltd.
- Lucigen Corporation
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Next Generation DNA Sequencing Market by Type
- 1.2.1 Global Next Generation DNA Sequencing Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Solexa Sequencing
- 1.2.3 454 Sequencing
- 1.2.4 Proton / PGM Sequencing
- 1.3 Next Generation DNA Sequencing Market by Application
- 1.3.1 Global Next Generation DNA Sequencing Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Universities & Other Research Entities
- 1.3.3 Hospitals & Clinics
- 1.3.4 Pharma & Biotech Entities
- 1.3.5 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Next Generation DNA Sequencing Market Dynamics
- 2.1 Next Generation DNA Sequencing Industry Trends
- 2.2 Next Generation DNA Sequencing Industry Drivers
- 2.3 Next Generation DNA Sequencing Industry Opportunities and Challenges
- 2.4 Next Generation DNA Sequencing Industry Restraints
3 Global Growth Perspective
- 3.1 Global Next Generation DNA Sequencing Market Perspective (2021-2032)
- 3.2 Global Next Generation DNA Sequencing Growth Trends by Region
- 3.2.1 Global Next Generation DNA Sequencing Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Next Generation DNA Sequencing Market Size by Region (2021-2026)
- 3.2.3 Global Next Generation DNA Sequencing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Next Generation DNA Sequencing Revenue by Players
- 4.1.1 Global Next Generation DNA Sequencing Revenue by Players (2021-2026)
- 4.1.2 Global Next Generation DNA Sequencing Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Next Generation DNA Sequencing Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Next Generation DNA Sequencing Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Next Generation DNA Sequencing Key Players Headquarters & Area Served
- 4.4 Global Next Generation DNA Sequencing Players, Product Type & Application
- 4.5 Global Next Generation DNA Sequencing Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Next Generation DNA Sequencing Market CR5 and HHI
- 4.6.3 2025 Next Generation DNA Sequencing Tier 1, Tier 2, and Tier 3
5 Next Generation DNA Sequencing Market Size by Type
- 5.1 Global Next Generation DNA Sequencing Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Next Generation DNA Sequencing Revenue by Type (2021-2032)
- 5.3 Global Next Generation DNA Sequencing Revenue Market Share by Type (2021-2032)
6 Next Generation DNA Sequencing Market Size by Application
- 6.1 Global Next Generation DNA Sequencing Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Next Generation DNA Sequencing Revenue by Application (2021-2032)
- 6.3 Global Next Generation DNA Sequencing Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Quest Diagnostics Incorporated
- 7.1.1 Quest Diagnostics Incorporated Company Information
- 7.1.2 Quest Diagnostics Incorporated Business Overview
- 7.1.3 Quest Diagnostics Incorporated Next Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
- 7.1.4 Quest Diagnostics Incorporated Next Generation DNA Sequencing Product Portfolio
- 7.1.5 Quest Diagnostics Incorporated Recent Developments
- 7.2 ARUP Laboratories
- 7.2.1 ARUP Laboratories Company Information
- 7.2.2 ARUP Laboratories Business Overview
- 7.2.3 ARUP Laboratories Next Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
- 7.2.4 ARUP Laboratories Next Generation DNA Sequencing Product Portfolio
- 7.2.5 ARUP Laboratories Recent Developments
- 7.3 Applied Biological Materials, Inc. (abm)
- 7.3.1 Applied Biological Materials, Inc. (abm) Company Information
- 7.3.2 Applied Biological Materials, Inc. (abm) Business Overview
- 7.3.3 Applied Biological Materials, Inc. (abm) Next Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
- 7.3.4 Applied Biological Materials, Inc. (abm) Next Generation DNA Sequencing Product Portfolio
- 7.3.5 Applied Biological Materials, Inc. (abm) Recent Developments
- 7.4 Novogene Co, Ltd.
- 7.4.1 Novogene Co, Ltd. Company Information
- 7.4.2 Novogene Co, Ltd. Business Overview
- 7.4.3 Novogene Co, Ltd. Next Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
- 7.4.4 Novogene Co, Ltd. Next Generation DNA Sequencing Product Portfolio
- 7.4.5 Novogene Co, Ltd. Recent Developments
- 7.5 Azenta Life Sciences (GENEWIZ)
- 7.5.1 Azenta Life Sciences (GENEWIZ) Company Information
- 7.5.2 Azenta Life Sciences (GENEWIZ) Business Overview
- 7.5.3 Azenta Life Sciences (GENEWIZ) Next Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
- 7.5.4 Azenta Life Sciences (GENEWIZ) Next Generation DNA Sequencing Product Portfolio
- 7.5.5 Azenta Life Sciences (GENEWIZ) Recent Developments
- 7.6 NanoString
- 7.6.1 NanoString Company Information
- 7.6.2 NanoString Business Overview
- 7.6.3 NanoString Next Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
- 7.6.4 NanoString Next Generation DNA Sequencing Product Portfolio
- 7.6.5 NanoString Recent Developments
- 7.7 Illumina, Inc.
- 7.7.1 Illumina, Inc. Company Information
- 7.7.2 Illumina, Inc. Business Overview
- 7.7.3 Illumina, Inc. Next Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
- 7.7.4 Illumina, Inc. Next Generation DNA Sequencing Product Portfolio
- 7.7.5 Illumina, Inc. Recent Developments
- 7.8 PacBio
- 7.8.1 PacBio Company Information
- 7.8.2 PacBio Business Overview
- 7.8.3 PacBio Next Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
- 7.8.4 PacBio Next Generation DNA Sequencing Product Portfolio
- 7.8.5 PacBio Recent Developments
- 7.9 Veritas
- 7.9.1 Veritas Company Information
- 7.9.2 Veritas Business Overview
- 7.9.3 Veritas Next Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
- 7.9.4 Veritas Next Generation DNA Sequencing Product Portfolio
- 7.9.5 Veritas Recent Developments
- 7.10 BGI (Beijing Genomics Institute)
- 7.10.1 BGI (Beijing Genomics Institute) Company Information
- 7.10.2 BGI (Beijing Genomics Institute) Business Overview
- 7.10.3 BGI (Beijing Genomics Institute) Next Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
- 7.10.4 BGI (Beijing Genomics Institute) Next Generation DNA Sequencing Product Portfolio
- 7.10.5 BGI (Beijing Genomics Institute) Recent Developments
- 7.11 Gene by Gene Ltd.
- 7.11.1 Gene by Gene Ltd. Company Information
- 7.11.2 Gene by Gene Ltd. Business Overview
- 7.11.3 Gene by Gene Ltd. Next Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
- 7.11.4 Gene by Gene Ltd. Next Generation DNA Sequencing Product Portfolio
- 7.11.5 Gene by Gene Ltd. Recent Developments
- 7.12 Lucigen Corporation
- 7.12.1 Lucigen Corporation Company Information
- 7.12.2 Lucigen Corporation Business Overview
- 7.12.3 Lucigen Corporation Next Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
- 7.12.4 Lucigen Corporation Next Generation DNA Sequencing Product Portfolio
- 7.12.5 Lucigen Corporation Recent Developments
8 North America
- 8.1 North America Next Generation DNA Sequencing Revenue (2021-2032)
- 8.2 North America Next Generation DNA Sequencing Revenue by Type (2021-2032)
- 8.2.1 North America Next Generation DNA Sequencing Revenue by Type (2021-2026)
- 8.2.2 North America Next Generation DNA Sequencing Revenue by Type (2027-2032)
- 8.3 North America Next Generation DNA Sequencing Revenue Share by Type (2021-2032)
- 8.4 North America Next Generation DNA Sequencing Revenue by Application (2021-2032)
- 8.4.1 North America Next Generation DNA Sequencing Revenue by Application (2021-2026)
- 8.4.2 North America Next Generation DNA Sequencing Revenue by Application (2027-2032)
- 8.5 North America Next Generation DNA Sequencing Revenue Share by Application (2021-2032)
- 8.6 North America Next Generation DNA Sequencing Revenue by Country
- 8.6.1 North America Next Generation DNA Sequencing Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Next Generation DNA Sequencing Revenue by Country (2021-2026)
- 8.6.3 North America Next Generation DNA Sequencing Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Next Generation DNA Sequencing Revenue (2021-2032)
- 9.2 Europe Next Generation DNA Sequencing Revenue by Type (2021-2032)
- 9.2.1 Europe Next Generation DNA Sequencing Revenue by Type (2021-2026)
- 9.2.2 Europe Next Generation DNA Sequencing Revenue by Type (2027-2032)
- 9.3 Europe Next Generation DNA Sequencing Revenue Share by Type (2021-2032)
- 9.4 Europe Next Generation DNA Sequencing Revenue by Application (2021-2032)
- 9.4.1 Europe Next Generation DNA Sequencing Revenue by Application (2021-2026)
- 9.4.2 Europe Next Generation DNA Sequencing Revenue by Application (2027-2032)
- 9.5 Europe Next Generation DNA Sequencing Revenue Share by Application (2021-2032)
- 9.6 Europe Next Generation DNA Sequencing Revenue by Country
- 9.6.1 Europe Next Generation DNA Sequencing Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Next Generation DNA Sequencing Revenue by Country (2021-2026)
- 9.6.3 Europe Next Generation DNA Sequencing Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Next Generation DNA Sequencing Revenue (2021-2032)
- 10.2 China Next Generation DNA Sequencing Revenue by Type (2021-2032)
- 10.2.1 China Next Generation DNA Sequencing Revenue by Type (2021-2026)
- 10.2.2 China Next Generation DNA Sequencing Revenue by Type (2027-2032)
- 10.3 China Next Generation DNA Sequencing Revenue Share by Type (2021-2032)
- 10.4 China Next Generation DNA Sequencing Revenue by Application (2021-2032)
- 10.4.1 China Next Generation DNA Sequencing Revenue by Application (2021-2026)
- 10.4.2 China Next Generation DNA Sequencing Revenue by Application (2027-2032)
- 10.5 China Next Generation DNA Sequencing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Next Generation DNA Sequencing Revenue (2021-2032)
- 11.2 Asia Next Generation DNA Sequencing Revenue by Type (2021-2032)
- 11.2.1 Asia Next Generation DNA Sequencing Revenue by Type (2021-2026)
- 11.2.2 Asia Next Generation DNA Sequencing Revenue by Type (2027-2032)
- 11.3 Asia Next Generation DNA Sequencing Revenue Share by Type (2021-2032)
- 11.4 Asia Next Generation DNA Sequencing Revenue by Application (2021-2032)
- 11.4.1 Asia Next Generation DNA Sequencing Revenue by Application (2021-2026)
- 11.4.2 Asia Next Generation DNA Sequencing Revenue by Application (2027-2032)
- 11.5 Asia Next Generation DNA Sequencing Revenue Share by Application (2021-2032)
- 11.6 Asia Next Generation DNA Sequencing Revenue by Country
- 11.6.1 Asia Next Generation DNA Sequencing Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Next Generation DNA Sequencing Revenue by Country (2021-2026)
- 11.6.3 Asia Next Generation DNA Sequencing Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Next Generation DNA Sequencing Revenue (2021-2032)
- 12.2 SAMEA Next Generation DNA Sequencing Revenue by Type (2021-2032)
- 12.2.1 SAMEA Next Generation DNA Sequencing Revenue by Type (2021-2026)
- 12.2.2 SAMEA Next Generation DNA Sequencing Revenue by Type (2027-2032)
- 12.3 SAMEA Next Generation DNA Sequencing Revenue Share by Type (2021-2032)
- 12.4 SAMEA Next Generation DNA Sequencing Revenue by Application (2021-2032)
- 12.4.1 SAMEA Next Generation DNA Sequencing Revenue by Application (2021-2026)
- 12.4.2 SAMEA Next Generation DNA Sequencing Revenue by Application (2027-2032)
- 12.5 SAMEA Next Generation DNA Sequencing Revenue Share by Application (2021-2032)
- 12.6 SAMEA Next Generation DNA Sequencing Revenue by Country
- 12.6.1 SAMEA Next Generation DNA Sequencing Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Next Generation DNA Sequencing Revenue by Country (2021-2026)
- 12.6.3 SAMEA Next Generation DNA Sequencing Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst